⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MDGL News
Madrigal Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
MDGL
Madrigal Pharmaceuticals to Release First-Quarter 2026 Financial Results and Host Webcast on May 6, 2026
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step
prnewswire.com
PRME
IOVA
MDGL
DNLI
Advanced Cell-based Therapy Booming the Success for Healthcare Sector
prnewswire.com
PRME
IOVA
MDGL
DNLI
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Condor Software Raises $24 Million Series A Funding to Build the First Financial Intelligence Platform for Life Sciences
prnewswire.com
BBIO
MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
MDGL
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
globenewswire.com
MDGL